Return to content in this issue

Are Biosimilars of Biologics the Same as the Reference Drug in Terms of Allergy? Selective Allergy to Tocilizumab Biosimilar

Betancor D^1,2, Gómez-López A¹, Barroso B^1,2, Valverde-Monge M^1,2, Cañas JA^2,3, Rodrigo-Muñoz JM^2,3, del Pozo V^2,3, Sastre J<sup>1,2

1</sup>Allergy Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
²CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain
³Immunoallergy Laboratory, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid

J Investig Allergol Clin Immunol 2025; Vol. 35(1)
doi: 10.18176/jiaci.1025

• Abstract
• Supplemental Materials

Key words: Tocilizumab, Biosimilar, Drug allergy

	Title	Type	Size
	doi10.18176_jiaci.1025_supplemental-materials-figure.pdf	pdf	109.22 Kb